Upstart Cell Biosciences Acquires Protein Forest as it Continues on Growth Curve | GenomeWeb

This story originally ran on Dec. 7.

By Tony Fong

Nano-proteomics technology development firm Cell Biosciences today announced that it has acquired sample preparation firm Protein Forest for an undisclosed price in a deal designed to accelerate its growth in the proteomics space.

In connection with the all-stock transaction, Cell Biosciences said it raised an additional $4 million in equity financing. Novo A/S, an existing investor in the firm, led the financing round.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.